APA (7th ed.) Citation

JG, K., KS, T., C, B., DL, B., KLR, B., KR, B., . . . RW, Y. (2018). Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective. Clinical pharmacology and therapeutics, 104(5), 916. https://doi.org/10.1002/cpt.1222

Chicago Style (17th ed.) Citation

JG, Kenna, et al. "Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective." Clinical Pharmacology and Therapeutics 104, no. 5 (2018): 916. https://doi.org/10.1002/cpt.1222.

MLA (9th ed.) Citation

JG, Kenna, et al. "Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective." Clinical Pharmacology and Therapeutics, vol. 104, no. 5, 2018, p. 916, https://doi.org/10.1002/cpt.1222.